| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 1,382,565 | 1,406,012 | 1,208,339 | 1,485,172 | | Cost of Revenue | 1,013,106 | 1,038,624 | 1,054,650 | 1,129,210 | | | Gross Profit | 369,459 | 367,388 | 153,689 | 355,962 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 301,388 | 292,710 | 299,573 | 324,892 | | Non Recurring |
-
|
-
|
-
| 124,485 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 68,071 | 74,678 | (145,884) | (93,415) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,657 | 5,568 | (1,637) | (18,352) | | Earnings Before Interest And Taxes | 69,728 | 80,246 | (147,521) | (111,767) | | Interest Expense | 32,318 | 30,002 | 30,184 | 30,001 | | Income Before Tax | 37,410 | 50,244 | (177,705) | (141,768) | | Income Tax Expense | 2,015 | 3,037 | (72,796) | (14,153) | | Minority Interest | (1,047) | (946) | (978) |
-
| | | | Net Income From Continuing Ops | 34,348 | 46,261 | (105,887) | (127,615) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,348 | 46,261 | (105,887) | (127,615) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $34,348 | $46,261 | ($105,887) | ($127,615) |
|
0.26% Nasdaq 
0.80 (1.61%) 
Income Statement
